PREDIX Pharmaceuticals (PRDX): Predix preliminary clinical trial of hyp...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	145
Posts	27727
Boards Moderated	3
Alias Born	02/07/2004

midastouch017

Re: None

Thursday, 04/20/2006 2:33:57 PM

Thursday, April 20, 2006 2:33:57 PM

Predix preliminary clinical trial of hypertension drug - successful
Predix Pharmaceuticals recently merged with the Nasdaq-traded EPIX Pharmaceuticals.

Gali Weinreb 20 Apr 06 16:03

Drug development company Predix Pharmaceuticals, announced today it had successfully completed a Phase Ib clinical trial to study the pharmacodynamics and tolerability of PRX-08066, a drug developed for treatment of elevated pulmonary artery pressures induced by low oxygen levels.
Founded in Israel and now registered in the US, Predix recently announced a definitive agreement to merge with EPIX Pharmaceuticals (Nasdaq: EPIX), in a agreement reflecting a value for Predix of $90 million. Epix develops imaging pharmaceuticals targeted at the molecular level for MRI imaging. The company has a pipeline of diagnostic pharmaceutical products for detection of various vascular and coronary diseases.

Published by Globes [online], Israel business news - www.globes.co.il - on April 20, 2006

Dubi